Daxor

DXR · NASDAQ

$9.75−$0.09 (−0.91%)TodayMarket closed ·
Prev close $9.84

About DXR

Daxor Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. The company specializes in blood volume measurement technology focused on blood volume testing innovation. The company markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. The company has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.

Employees
0
Headquarters
Oak Ridge, Tennessee
Listed
Jul 25, 1983
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
daxor.com

Leadership

Daxor executives
NameTitleSince
Michael Feldschuh—2013
Robert Michel——
Jonathan Feldschuh—2016
John Jefferies——
Henry Cremisi——
Caleb Desrosiers——
Edward Feuer——
Joy Goudie——
Bret Shapiro—2021

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Daxor suppliers and customers
CompanyRelationshipCorrelation
Concordance Healthcare Solutions LLCSupplier and customer—
L1 Enterprises, Inc.Supplier and customer—
United StatesCustomer—

Similar companies

Companies in the same industry as Daxor

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.